G. Marsche, M. Saemann, A. Heinemann, and M. Holzer, Inflammation alters HDL composition and function: Implications for HDL-raising therapies, Pharmacology & Therapeutics, vol.137, issue.3, pp.341-351, 2013.
DOI : 10.1016/j.pharmthera.2012.12.001

P. Davidsson, J. Hulthe, B. Fagerberg, and G. Camejo, Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.2, pp.156-163, 2010.
DOI : 10.1161/ATVBAHA.108.179317

A. Kontush, M. Lhomme, and M. Chapman, Unraveling the complexities of the HDL lipidome, The Journal of Lipid Research, vol.54, issue.11, p.393
DOI : 10.1194/jlr.R036095

M. Lagarde, B. Drouot, M. Guichardant, and M. Dechavanne, In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.833, issue.1, pp.52-58, 1985.
DOI : 10.1016/0005-2760(85)90252-8

R. Colas, A. Sassolas, M. Guichardant, C. Cugnet-anceau, M. Moret et al., LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets, Diabetologia, vol.29, issue.11, pp.2931-2940, 2011.
DOI : 10.1007/s00125-011-2272-8
URL : https://hal.archives-ouvertes.fr/inserm-00616814

J. Therasse and F. Lemonnier, Determination of plasma lipoperoxides by high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.413, pp.237-241, 1987.
DOI : 10.1016/0378-4347(87)80232-3

C. Calzada, L. Coulon, D. Halimi, L. Coquil, E. Pruneta-deloche et al., Glycoxidized Low-Density Lipoproteins and Low-Density Lipoproteins Isolated from Type 2 Diabetic Patients Activate Platelets via p38 Mitogen-Activated Protein Kinase, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.5, pp.1961-1964, 2007.
DOI : 10.1210/jc.2006-2045
URL : https://hal.archives-ouvertes.fr/inserm-00267256

J. Nofer, M. Walter, B. Kehrel, S. Wierwille, M. Tepel et al., HDL3-Mediated Inhibition of Thrombin-Induced Platelet Aggregation and Fibrinogen Binding Occurs via Decreased Production of Phosphoinositide-Derived Second Messengers 1,2-Diacylglycerol and Inositol 1,4,5-tris-Phosphate, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.18, issue.6, pp.861-869, 1998.
DOI : 10.1161/01.ATV.18.6.861